Lung transplantation is a life-saving therapy for adults with advanced lung diseases, such as interstitial lung disease and chronic obstructive pulmonary disease. The success of lung transplantation is limited by poor early and late outcomes. Primary graft dysfunction (PGD), a form of acute lung injury (ALI) occurring within 72 hours of lung transplantation, is the leading cause of death early after lung transplantation and contributes to chronic lung allograft dysfunction. We have identified obesity as a novel risk facto for PGD. The mechanism underlying this association is not known, but obesity-related inflammation could contribute. Obesity is characterized by a chronic systemic inflammatory state due to the accumulation of pro-inflammatory adipose tissue macrophages (ATMs), T cells, and other immune cells. Adipocytes and ATMs secrete inflammatory mediators, chemoattractants, and adipokines, such as leptin, visfatin, and resistin, that could contribute to the development of ALI. The Lung Transplant Body Composition (LTBC) study is a multicenter cohort study testing the hypothesis that adipose tissue inflammation increases during lung transplant surgery and contributes to PGD, and specifically that pro-inflammatory ATMs and T cells drive this process. In this K24 Award, I propose an ancillary study to the LTBC study that will test the hypotheses that the inflammatory profile of subcutaneous adipose tissue obtained prior to lung transpalntation can (1) help identify individuals with an inflammatory profile in intrathoracic adipose tissue obtained during lung transplant surgery, and (2) is associated with greater disease severity in interstitial lung disease. With this K24 Award, I will develop additional mentorship skills and directly mentor additional trainees throughout the Award period. I also propose to develop the Pulmonary Fibrosis Foundation Scholars Program, a multicenter mentorship program designed to train fellows and junior faculty in clinical and translational patient-oriented research methods in interstitial lung disease. The proposal is innovative in nesting a translational study examining adipose tissue inflammation in an epidemiological cohort study of lung transplant candidates with interstitial lung disease. This work will lead to phase II clinical trials to decrease PGD risk in at-risk candidates identified through an inflammatory subcutaneous adipose tissue profile.

Public Health Relevance

One out of 5 adults who undergo lung transplantation dies within the first year of transplantation, most commonly as a consequence of damage to the new lungs early after transplantation. Overweight and obese adults undergoing lung transplantation are twice as likely as others to suffer from this early damage. We will determine if inflammation in subcutaneous fat can help identify those with inflammation in the fat in the chest at the time of transplant surgery.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Midcareer Investigator Award in Patient-Oriented Research (K24)
Project #
1K24HL131937-01
Application #
9086954
Study Section
Special Emphasis Panel (MCBS (JA))
Program Officer
Colombini-Hatch, Sandra
Project Start
2016-09-01
Project End
2021-07-31
Budget Start
2016-09-01
Budget End
2017-07-31
Support Year
1
Fiscal Year
2016
Total Cost
$117,438
Indirect Cost
$8,699
Name
Columbia University (N.Y.)
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Singer, Jonathan P; Diamond, Joshua M; Anderson, Michaela R et al. (2018) Frailty phenotypes and mortality after lung transplantation: A prospective cohort study. Am J Transplant 18:1995-2004
Gannon, Whitney D; Lederer, David J; Biscotti, Mauer et al. (2018) Outcomes and Mortality Prediction Model of Critically Ill Adults With Acute Respiratory Failure and Interstitial Lung Disease. Chest 153:1387-1395
Bernstein, Elana J; Khanna, Dinesh; Lederer, David J (2018) Screening High-Resolution Computed Tomography of the Chest to Detect Interstitial Lung Disease in Systemic Sclerosis: A Global Survey of Rheumatologists. Arthritis Rheumatol 70:971-972
Maldonado, Dawn A; RoyChoudhury, Arindam; Lederer, David J (2018) A novel patient-centered ""intention-to-treat"" metric of U.S. lung transplant center performance. Am J Transplant 18:226-231
Madahar, Purnema; Duprez, Daniel A; Podolanczuk, Anna J et al. (2018) Collagen biomarkers and subclinical interstitial lung disease: The Multi-Ethnic Study of Atherosclerosis. Respir Med 140:108-114
Bernstein, Elana J; Bathon, Joan M; Lederer, David J (2018) Survival of adults with systemic autoimmune rheumatic diseases and pulmonary arterial hypertension after lung transplantation. Rheumatology (Oxford) 57:831-834
Manichaikul, Ani; Sun, Li; Borczuk, Alain C et al. (2017) Plasma Soluble Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis. Ann Am Thorac Soc 14:628-635
Diamond, J M; Cantu, E; Porteous, M K et al. (2017) Peripheral Blood Gene Expression Changes Associated With Primary Graft Dysfunction After Lung Transplantation. Am J Transplant 17:1770-1777
Restivo, Michaela D; Podolanczuk, Anna; Kawut, Steven M et al. (2017) Antacid use and subclinical interstitial lung disease: the MESA study. Eur Respir J 49:
Pollack, Lauren R; Goldstein, Nathan E; Gonzalez, Wendy C et al. (2017) The Frailty Phenotype and Palliative Care Needs of Older Survivors of Critical Illness. J Am Geriatr Soc 65:1168-1175

Showing the most recent 10 out of 28 publications